RxSight (RXST) Revenue (2020 - 2026)

RxSight (RXST) has reported Revenue for 7 consecutive years, with $33.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue changed 0.31% year-over-year to $33.7 million; the trailing twelve-month figure through Jun 2026 stood at $127.6 million (down 13.24% YoY), and the FY2025 full-year result was $134.5 million, down 3.89% from the prior year.
• Revenue climbed to $33.7 million in Q2 2026 per RXST's latest filing, from $30.9 million in the prior quarter.
• Across five years, Revenue topped out at $40.2 million in Q4 2024 and bottomed at $8.9 million in Q1 2022.
• Historically, Revenue has averaged $26.5 million across 5 years, with a median of $29.9 million in 2024.
• The sharpest annual moves came in 2022 and 2025: Revenue soared 156.66% in 2022, then slipped 18.91% in 2025.
• Over 5 years, Revenue stood at $16.1 million in 2022, then jumped by 77.65% to $28.6 million in 2023, then soared by 40.71% to $40.2 million in 2024, then dropped by 18.91% to $32.6 million in 2025, then advanced by 3.47% to $33.7 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $33.7 million, $30.9 million, and $32.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.